Report Categories
View AllRecent Articles
View All
Sturm RGR Stock Price Direction Insight Sturm Posts 34 EPS Miss Amid Softening Firearm Demand
Intel Corporation INTC Stifel Raises Price Target on Foundry Progress Turnaround Thesis Remains ExecutionDependent
Why Kura Sushi KRUS could deliver where others fall short 046 20260511
Is Coherus CHRS stock losing upward momentum Bullish Sentiment 20260420
PNW Pinnacle earnings demolish estimates with massive 2331 percent EPS beat stock ticks higher on cautious investor response
Is Vine Hill VCICW stock a good investment this year
Edison International EIX Q1 2026 Earnings InLine With Consensus Analyst Outlooks Remain Neutral PostPrint
Kinross KGC Stock Is It Losing Market Strength Q1 2026 Earnings Fall Short
Marathon Petroleum MPC Valuation Gap Analysis Post Recent Share Volatility and DCF Modelling
MaxLinear Surges Nearly 300 on Trinity Platform Launch Catches Hedge Fund Attention
Wheeler WHLRD Steady at 3551 Awaiting Next Catalyst 20260518
Trump Departs Beijing After Trade Oil and Taiwan Talks Dominate Summit
CCH Holdings CCHH Stock Analysis Falls 216 Watching 036 20260518
Stellantis Unveils 70 Billion Turnaround Plan Targets Positive Cash Flow by 2028
KALA BIO KALA Delivers Q4 2025 Beat EPS 3350 vs 7344 Expected
Nvidia Stock Declines PostEarnings SpaceX Submits IPO Filing Details
South Korean Shares Surge 8 as Samsung Electronics Reaches Record High on Labor Deal
PAYO Q1 2026 Earnings EPS Surprises to the Upside Stock Slightly Lower After Report
Transocean Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Offshore Market
BIOA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage
Home Depot Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operating Trends
Catalyst Bancorp Inc CLST Q3 2025 Earnings Modest Profitability Amid Quiet Quarter
Newell Brands NWL Edges Higher Can the Turnaround Story Gain Traction
Abeona Therapeutics ABEO Slips 145 as Stock Tests Key Support at 517
AEFC Holds Steady at 1917 Amid Low Volatility FixedIncome Stability in Focus
Protalix BioTherapeutics PLX Rises 143 as Biotech Stock Tests Key Resistance